CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Mylan NV Company Snapshot
Mylan NV operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Mylan NV with three other companies in this sector in UNITED STATES : Daiichi Sankyo Company Limited (2019 sales of $8.38 billion of which 93% was Prescription drugs), Regeneron Pharmaceuticals Incorporated ($7.86 billion of which 59% was EYLEA), and CSL Limited ($8.54 billion of which 84% was CSL Behring).

Sales Analysis. Mylan NV reported sales of $11.50 billion for the year ending December of 2019. This represents a very small increase of 0.6% versus 2018, when the company's sales were $11.43 billion. Despite this increase, sales are still below the level achieved in 2017, when Mylan NV reported sales of $11.91 billion. Sales of Rest of World saw an increase that was more than double the company's growth rate: sales were up 5.5% in 2019, from $3.04 billion to $3.21 billion. Not all segments of Mylan NV experienced an increase in sales in 2019: sales of Europe fell 3.1% to $4.05 billion.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Mylan NV
  Stock Performance Chart for Mylan NV
 
  Stock Data: Recent Stock Performance:
  Current Price (7/31/2020): 16.11
(Figures in U.S. Dollars)
1 Week 0.9%   13 Weeks 1.1%  
4 Weeks -0.1%   52 Weeks -18.8%  
 
Mylan NV Key Data:
  Ticker: MYL Country: United Kingdom
  Exchanges: NAS FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 11,500,500,000
(Year Ending Jan 2020).
Employees: 35,000
  Currency: U.S. Dollars Market Cap: 8,327,971,384
  Fiscal Yr Ends: December Shares Outstanding: 516,944,220
  Share Type: Common Closely Held Shares: 7,108,286
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.